Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mass Balance and Pharmacokinetics of [14C]-GSK3640254
NCT04507321Phase 1Completed
- Sponsor
- ViiV Healthcare
- Start
- Sep 2020
- Primary completion
- Nov 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of fipravirimat in human immunodeficiency virus infection (HIV), sponsored by ViiV Healthcare. Primary endpoints: Area Under the Concentration-time Curve From Time Zero Extrapolated to Infinite Time, Area Under the Concentration-time Curve From Time Zero to Last Time of Quantifiable Concentration and 14 more. Started Sep 2020; status: completed.
02
Drugs
fipravirimat
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT04507321.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04507321.